Extract
Bronchiectasis is a disease defined by a permanent and usually progressive bronchial dilation associated with multiple exacerbations and decreased health-related quality of life [1–3]. Improvement in the current knowledge of this condition's pathophysiology has clearly highlighted its complex and heterogeneous profile, whose severity or prognosis cannot be defined using a single variable [4]. Accordingly, multidimensional scores including demographical, clinical, microbiological and radiological data have recently been developed and validated as useful tools to better evaluate the disease's severity and prognosis: FACED (forced expiratory volume in 1 s (FEV1), age, chronic colonisation by Pseudomonas aeruginosa, radiological extension and dyspnoea), E-FACED (FACED plus exacerbations) and the bronchiectasis severity index (BSI) [5–8].
Abstract
Both FACED and E-FACED scores have shown good short-term prognostic value for predicting mortality in bronchiectasis http://ow.ly/albl30i11bv
Footnotes
Conflict of interest: None declared.
Authors' contributions to the study: D. de la Rosa, R. Athanazio and M.A. Martínez-García designed the study, contributed to data acquisition and interpretation, supervised the study, and wrote the manuscript. The other authors contributed to data acquisition and interpretation, critically revised the manuscript, and approved the final version to be published.
- Received November 4, 2017.
- Accepted January 18, 2018.
- Copyright ©ERS 2018
This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.